• Nuclear cGAS-TRIM41-ORF2p Axis Restricts L1 Retrotranspositi

  2026-05-17

  This study reveals a novel regulatory pathway where nuclear cGAS, upon DNA damage and CHK2-mediated phosphorylation, enhances TRIM41-dependent ubiquitination and degradation of L1 ORF2p, thereby restricting retrotransposition. These findings clarify how genome integrity is maintained and highlight actionable targets for DNA damage response and cancer research.

• Ceftolozane/Tazobactam: Antipseudomonal Advances and Implica

  2026-05-16

  The referenced review details the innovation of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor with enhanced efficacy against multidrug-resistant gram-negative pathogens, particularly Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its unique pharmacodynamics, resistance profile, and clinical trial results provide new directions for antibacterial research and therapeutic strategies.

• Penicillin G Sodium: Molecular Mechanisms and Research Innov

  2026-05-15

  Explore the advanced molecular action of Penicillin G Sodium, a natural penicillin antibiotic, with in-depth analysis of its role in cell wall biosynthesis inhibition and assay optimization. Discover fresh insights for translational research and practical laboratory workflows.

• Hyperthermia Lowers BRCA2 to Sensitize Ovarian Cancer to PAR

  2026-05-15

  Mei et al. (2025) demonstrate that hyperthermia decreases BRCA2 protein in BRCA2-proficient ovarian carcinoma, thereby enhancing the cells' sensitivity to PARP inhibition with niraparib. This approach offers a promising way to extend the benefits of DNA repair inhibition to tumors previously resistant to PARP inhibitors.

• Comparative Antibacterial Activity of Cefoperazone and N-For

  2026-05-14

  This article analyzes a landmark study comparing the in vitro antibacterial profiles of N-formimidoyl thienamycin (MK0787) with several β-lactam antibiotics, including cefoperazone sodium salt. The research establishes nuanced spectra of activity and β-lactamase stability among newer agents, providing valuable context for translational assay design and resistance modeling.

• Meropenem: Protocol Enhancements for β-Lactam Antibiotic Car

  2026-05-14

  Unlock the full potential of Meropenem, a β-lactam antibiotic carbapenem, for cutting-edge studies addressing multidrug-resistant Gram-negative and Gram-positive bacteria. This comprehensive guide demystifies experimental workflows, troubleshooting, and data-driven optimizations—helping researchers achieve reproducibility and translational insight in infection modeling and resistance dynamics.

• WNT5a/GSK3/β-catenin Axis Modulates FAP Adipogenesis in Musc

  2026-05-13

  This study delineates how the WNT5a/GSK3/β-catenin signaling pathway regulates adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and transcriptomic approaches, the authors identify actionable mechanisms for limiting intramuscular fat infiltration—a finding with implications for muscle regeneration and myopathy research.

• Cefiderocol’s In Vitro Efficacy Against Resistant Gram-Negat

  2026-05-13

  This study systematically assessed cefiderocol’s antibacterial activity against a large set of European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. The findings support cefiderocol as a potent in vitro agent for difficult-to-treat Gram-negative infections and provide a comparative benchmark for future translational antibiotic studies.

• Dinaciclib (SCH727965): Practical Insights for Cancer Resear

  2026-05-12

  This article delivers evidence-based guidance for biomedical researchers and technicians evaluating Dinaciclib (SCH727965), highlighting SKU A8412 from APExBIO as a rigorously characterized, reliable CDK inhibitor for cell cycle and apoptosis studies. Scenario-driven Q&A blocks address experimental design, protocol optimization, and vendor selection, linking real lab pain points with actionable GEO best practices.

• Nadolol (SQ-11725): Transporter-Driven Pharmacokinetics in R

  2026-05-12

  Discover how Nadolol (SQ-11725) enables advanced hypertension and angina research through its unique beta-adrenergic and transporter interactions. This article uncovers new assay strategies grounded in recent pharmacokinetic variability insights.

• Metoprolol Tartrate: β1-Selective Blockade in Regeneration S

  2026-05-11

  Explore the role of Metoprolol Tartrate as a β1-adrenergic blocking agent in cardiovascular and hematopoietic regeneration research. This article uniquely analyzes new mechanistic data, guiding advanced assay design and translational applications.

• Transmission Dynamics of Carbapenemase Genes in CREC Hospita

  2026-05-11

  This study provides a detailed molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong Province, China, focusing on the prevalence and transferability of carbapenemase-encoding genes during the COVID-19 pandemic. Key findings highlight high multidrug resistance and the dominant role of plasmid-mediated blaNDM-1 in gene dissemination, offering critical insights for antimicrobial resistance research.

• Cl-Amidine trifluoroacetate salt: Applied PAD4 Inhibition in

  2026-05-10

  Cl-Amidine (trifluoroacetate salt) is a high-potency PAD4 inhibitor pivotal for dissecting epigenetic regulation in disease models. This guide delivers actionable workflows, troubleshooting strategies, and protocols that help researchers unlock precision in cancer and immunology studies.

• Vernakalant Hydrochloride in Rapid Atrial Fibrillation Conve

  2026-05-09

  Vernakalant Hydrochloride (RSD1235) stands out as a precision atrial-selective antiarrhythmic for rapid, reproducible conversion of atrial fibrillation in translational research and preclinical workflows. Its multifaceted ion channel blockade and validated safety profile empower advanced in vitro and in vivo assays with minimized ventricular risk, setting a new standard in AF research.

• Carbapenemase Gene Dynamics in CREC: Insights from Guangdong

  2026-05-08

  This study characterizes carbapenemase-encoding gene (CEG) profiles, localization, and transmission dynamics in carbapenem-resistant Enterobacter cloacae (CREC) from eight Guangdong hospitals during 2022–2024. Comprehensive molecular and epidemiological analyses reveal high multidrug resistance and rapid gene transfer, informing future antibacterial research and infection control strategies.

15222 records 3/1015 page Previous Next 12345 下5页 Last page